---
layout: default
title: Abies Alba Leafy Twig Bos Taurus Gallstone Calcium
parent: 僅模型預測 (L5)
nav_order: 45
evidence_level: L5
indication_count: 0
---

# Abies Alba Leafy Twig Bos Taurus Gallstone Calcium
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Complex (24 Components): Insufficient Data for Repurposing Evaluation

## One-Sentence Summary

This candidate is a 24-component multi-ingredient formulation comprising calcium salts, botanical extracts, animal-derived substances, and homeopathic constituents, with no established approved indication on record.
The TxGNN model returned **no predicted indications** for this entry, likely due to the absence of a single mappable DrugBank identifier and the highly heterogeneous ingredient list.
As a result, **no clinical trial or literature evidence** can be linked to a repurposing direction at this time.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available (no approved indication on record) |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A (no predictions generated) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

The TxGNN model operates by mapping a drug's DrugBank identifier into a biomedical knowledge graph and traversing disease–gene–protein relationships to surface repurposing candidates.
This entry has **no DrugBank ID** (`drugbank_id: null`), which means no node exists in the knowledge graph to serve as a starting point for traversal.

The ingredient list contains 24 heterogeneous substances — including inorganic calcium salts (e.g., calcium arsenate, calcium fluoride), homeopathic botanicals (e.g., *Calendula officinalis*, *Urtica urens*, *Hamamelis virginiana*), and animal-derived components (e.g., bovine gallstone, porcine parathyroid gland).
Such multi-ingredient homeopathic complexes are typically **not registered as discrete entities** in DrugBank or standard pharmacological databases, making knowledge-graph-based prediction technically infeasible without prior ingredient decomposition and individual mapping.

---

## US Market Information

No US NDA or regulatory authorization was found for this formulation.

---

## Safety Considerations

Please refer to the package insert for safety information.

> **Note:** Package insert data (warnings, contraindications) could not be retrieved (Data Gap DG001 — Blocking severity). Drug interaction screening returned no results. Safety evaluation cannot be completed without resolving this gap.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN model produced no repurposing candidates for this entry because the formulation lacks a DrugBank ID and is not representable as a single node in the knowledge graph; without a prediction to evaluate, there is no repurposing direction to assess.

**To proceed, the following is needed:**

1. **Ingredient decomposition** — Determine whether any single active ingredient (e.g., Vitamin D, Calcium, Cholesterol) can be evaluated independently using TxGNN; resubmit each as a separate candidate.
2. **DrugBank mapping** — Identify DrugBank IDs for individual pharmacologically active components before re-running the prediction pipeline.
3. **Clarify therapeutic intent** — Establish the intended or historical use of this formulation (homeopathic, naturopathic supplement, etc.) to determine whether knowledge-graph-based repurposing is the appropriate evaluation framework.
4. **Retrieve package insert data** — Resolve Data Gap DG001 (Blocking) by downloading and parsing the TFDA product monograph PDF to obtain warnings, contraindications, and approved indications.
5. **MOA documentation** — Resolve Data Gap DG002 (High) by querying DrugBank for mechanism-of-action data on individual identifiable components.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

